Ö. Can Bostan Et Al. , "Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study," Journal of Asthma , vol.60, no.5, pp.931-937, 2023
Can Bostan, Ö. Et Al. 2023. Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study. Journal of Asthma , vol.60, no.5 , 931-937.
Can Bostan, Ö., Duran, E., Tuncay, G., Cihanbeylerden, M., Karadag, O., Damadoglu, E., ... Karakaya, G.(2023). Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study. Journal of Asthma , vol.60, no.5, 931-937.
Can Bostan, ÖZGE Et Al. "Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study," Journal of Asthma , vol.60, no.5, 931-937, 2023
Can Bostan, ÖZGE C. Et Al. "Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study." Journal of Asthma , vol.60, no.5, pp.931-937, 2023
Can Bostan, Ö. Et Al. (2023) . "Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study." Journal of Asthma , vol.60, no.5, pp.931-937.
@article{article, author={ÖZGE CAN BOSTAN Et Al. }, title={Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study}, journal={Journal of Asthma}, year=2023, pages={931-937} }